Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Treasury Shares (2025)

Kura Oncology (KURA) has disclosed Treasury Shares for 1 consecutive years, with $436667.0 as the latest value for Q4 2025.

  • On a quarterly basis, Treasury Shares changed N/A to $436667.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $436667.0, a N/A change, with the full-year FY2025 number at $436667.0, changed N/A from a year prior.
  • Treasury Shares was $436667.0 for Q4 2025 at Kura Oncology, down from $775534.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $775534.0 in Q3 2025 to a low of $436667.0 in Q4 2025.